abstract |
The present invention encompasses compounds of the general formula (1) n n n n n n n n n n in whichn nR 1 to R 3 are defined as in claim 1 , which are suitable for treating diseases which are characterized by excessive or anomalous cell proliferation, and their use for producing a pharmaceutical having the abovementioned properties. |